Poor
Needs Revision
Patient Risk:
Moderate
Summary
Most statements are not evaluated against the provided label excerpts (abuse/misuse/addiction/diversion only), and several claims (e.g., side effects and specific cost/patent/patient-assistance statements) are unsupported by the supplied prescribing information. Multiple medication fact and safety-adjacent claims are therefore unsupported or not corroborated by the provided label text.
Category Scores
Accurate Statements
Adderall is a stimulant medication.
Unsupported by the provided label excerpts; the excerpts focus on abuse/misuse/addiction/diversion and do not explicitly define Adderall as a stimulant.
Adderall can lead to abuse/misuse/addiction and can be diverted for non-medical use; misuse/abuse can result in overdose and death.
Supported by SECTION 5 (high potential for abuse/misuse; can lead to substance use disorder including addiction; can be diverted) and SECTION 8 (high potential for abuse/misuse; diverted; overdose/death).
Unsupported Statements
Adderall XR (extended-release) 30-day supply without insurance can range from approximately $150 to over $300.
Not supported by any provided prescribing information excerpts.
Immediate-release Adderall can cost between $60 and $160 for a 30-day quantity without insurance.
Not supported by any provided prescribing information excerpts.
Insurance plans can reduce out-of-pocket expenses for Adderall.
Not supported by any provided prescribing information excerpts.
Most insurance plans cover prescription medications.
Not supported by any provided prescribing information excerpts.
The exact copay or coinsurance amount depends on the specific plan's formulary and tiering.
Not supported by any provided prescribing information excerpts.
Generic versions of Adderall are widely available.
Not supported by any provided prescribing information excerpts.
Generic versions of Adderall may be covered by insurance at a lower tier than brand-name formulations.
Not supported by any provided prescribing information excerpts.
Brand-name Adderall XR typically costs more than its generic equivalent (amphetamine and dextroamphetamine salts).
Not supported by any provided prescribing information excerpts.
Generic versions of Adderall are often more budget-friendly than brand-name formulations.
Not supported by any provided prescribing information excerpts.
Patent exclusivity for brand-name medications determines when generic versions can enter the market.
Not supported by any provided prescribing information excerpts.
Information on specific patent expiry dates for Adderall and its formulations can be found through specialized resources like DrugPatentWatch.com.
Not supported by any provided prescribing information excerpts.
Using generic versions can help reduce the cost of Adderall.
Not supported by any provided prescribing information excerpts.
Comparing prices across different pharmacies can help reduce the cost of Adderall.
Not supported by any provided prescribing information excerpts.
Prescription discount cards or coupons can help reduce the cost of Adderall.
Not supported by any provided prescribing information excerpts.
Patient assistance programs offered by manufacturers can help reduce the cost of Adderall.
Not supported by any provided prescribing information excerpts.
Patient assistance programs are more common for newer, high-cost drugs.
Not supported by any provided prescribing information excerpts.
Adderall is used to treat Attention Deficit Hyperactivity Disorder (ADHD).
The provided label excerpts do not include indications; no supporting label text for ADHD use was provided.
Adderall is used to treat narcolepsy.
The provided label excerpts do not include indications; no supporting label text for narcolepsy use was provided.
Common side effects of Adderall can include decreased appetite.
Provided excerpts discuss symptoms observed with misuse/abuse (SECTION 8) but do not establish as 'common side effects' in the adverse reactions section; not supported by provided adverse reaction labeling.
Common side effects of Adderall can include dry mouth.
Not supported by the provided label excerpts.
Common side effects of Adderall can include insomnia.
The excerpts mention restlessness/insomnia in the context of misuse/abuse (SECTION 8) but do not support a 'common side effects' claim from adverse reactions.
Common side effects of Adderall can include headache.
Not supported by the provided label excerpts.
Common side effects of Adderall can include weight loss.
Not supported by the provided label excerpts.
Common side effects of Adderall can include increased blood pressure.
The excerpts mention increased blood pressure with misuse/abuse (SECTION 8) but do not support a 'common side effects' claim.
More serious risks of Adderall can include cardiovascular problems.
Not directly supported by the provided excerpts; the excerpts list physiologic changes with misuse/abuse but do not state 'cardiovascular problems' as a risk category in the provided text.
More serious risks of Adderall can include psychiatric issues.
SECTION 8 mentions anxiety, psychosis, hostility, aggression, and suicidal/homicidal ideation with abuse/misuse, but the statement is broader ('psychiatric issues') and is not supported as a labeled 'more serious risks' phrasing in the provided excerpt.
More serious risks of Adderall can include the potential for abuse or dependence.
Potential abuse/misuse and development of substance use disorder including addiction is supported (SECTION 5/8), but 'dependence' specifically is not supported explicitly in the provided excerpts as wording/term.
Contradictions
Low
AI Statement
None of the provided statements directly contradict the supplied label excerpts on abuse/misuse/addiction/diversion.
Label Reference
N/A
Important Omissions
No label-supported dosage, administration, contraindications, boxed warnings, monitoring, storage, or adverse reaction profile content was provided to evaluate most dosing/safety-related claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims about indications and 'common side effects' are not supported by the provided prescribing information excerpts. While the abuse/misuse/addiction/diversion content aligns with the supplied label sections, unsupported clinical and safety-adjacent claims could mislead readers.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Needs Revision
Primary Issue
Most statements (cost/insurance/patent resources/patient assistance and multiple side-effect and indication claims) are not supported by the provided prescribing information excerpts. Only abuse/misuse/addiction/diversion risk content is supported.
Suggested Improvement
Limit claims strictly to what is present in the provided label text (e.g., abuse/misuse/addiction/diversion risk language). Omit cost/insurance/patent/resource/coupon/PAP statements and avoid asserting indications or 'common side effects' unless those specific sections are supplied and matched to the exact label wording.